See also this year's filing and all EDGAR filings for this company.
PDF Report 0001439222_2022_Agios_Pharmaceuticals_INC.pdf
Logs
Graph
Absolute values for 0001439222, Agios Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,064,231,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 28,923,000 |
| 3 | remainder_Assets | 344,582,000 |
| 4 | LiabilitiesCurrent | 59,826,000 |
| 5 | LiabilitiesNoncurrent | 85,659,000 |
| 6 | remainder_Liabilities | 276,000 |
| 7 | CostOfGoodsAndServicesSold | 2,787,286 |
| 8 | SellingGeneralAndAdministrativeExpense | 77,722,138 |
| 9 | ResearchAndDevelopmentExpense | -47,037,029 |
| 10 | remainder_Expenses | 17,704,662 |
| 11 | remainder_Revenues | 202,259,715 |
| 12 | remainder_NetIncome | 41,503,167 |
| 13 | remainder_ComprehensiveNetIncome | -1,053,968 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,437,736,000 |
| 1 | Liabilities | 145,761,000 |
| 2 | Expenses | 51,177,057 |
| 3 | Revenues | 202,259,715 |
| 4 | StockholdersEquity | 1,291,975,000 |
| 5 | NetIncome | 192,585,825 |
| 6 | ComprehensiveNetIncome | 192,058,841 |
| 7 | BaseVar | 939,745,454 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.80 |
| 9 | EconomicCapitalRatio | 4.24 |
Edgar->Model Mapping
Feature Distribution
Change over Time
